Podcast 21 Nov 2025How to succeed at BIO-Europe: DISCO Pharma takes us behind the scenes Labiotech followed one biotech heading into their first BIO-Europe partnering conference: cancer therapeutics company DISCO Pharma. November 21, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 14 Nov 2025Meet Fusix Biotech: 2025 BIO-Europe Startup Spotlight champion revolutionizing oncology Labiotech sat down with Jennifer Altomonte, co-founder of the BioEurope Startup Spotlight finalist, Fusix Biotech, who discussed Fusix’s cancer platform technology. November 14, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 7 Nov 2025Next‑generation UTI diagnostics: delivering results in just 35 minutes Llusern’s Lodestar DX aims to improve urinary tract infection diagnostics. It has created a test that detects pathogens in just 35 minutes, no lab required. November 7, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 31 Oct 2025How AI Is revolutionizing synthetic biology and biomanufacturing Today, with Héctor García Martín, scientist Lawrence Berkeley National Laboratory we’ll dive into why biology has proven so hard to engineer, how AI and robotics are changing that. October 31, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 24 Oct 2025Pichia pastoris: the microbial protein expression platform you’re probably underestimating Today we’re diving into the world of expression systems with Iskandar Dib, of Validogen and we’ll explore the remarkable potential of Pichia pastoris. October 24, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 17 Oct 2025Biotech royalty deals on the rise and here to stay In today’s episode, we welcome Clarke Futch, Chairman and CEO of HealthCare Royalty Partners, or HCRx, with a thirty year track record in biopharma investing. October 17, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 10 Oct 2025Contraline’s ADAM in the clinic: towards a new era of male contraception? In this week’s podcast we talked with Kevin Eisenfrats, CEO of Contraline, about contraception, male contraception. October 10, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 3 Oct 2025Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play This week, we discussed funding with Gerard Caelles, Chief Business Office of Splice Bio, a company that just closed a $135 million series B round. October 3, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 26 Sep 2025What’s next in immunology & inflammation R&D: The trends to watch This week’s guest is Joseph Ferner of Inpart, the author of a new R&D Trends Report on Immunology and Inflammation. Together we discussed the research landscape September 26, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 19 Sep 2025BIOSPAIN 2025: Why 1000 companies from more than 40 countries will gather in Barcelona this year This week, we sat down with Stewart Medina fromBIOSPAIN, one of the largest industry partnering events in Europe. September 19, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 12 Sep 2025AION Labs is building innovative biotechs with top pharma partners in Israel Our guest today is Mati Gill, CEO of AION Labs. AION Labs has an innovative company creation process that empowers startups to tackle high-impact challenges with AI, backed by top-tier data, funding, and expertise. September 12, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 5 Sep 2025Navigating the biotech development journey from first steps to global scale with Lonza Our guests Alice Harrison and Megan Mason from Lonza discuss how the company is helping innovators develop and scale their therapies. September 5, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More